SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-010356
Filing Date
2014-02-13
Accepted
2014-02-13 16:16:27
Documents
2
Period of Report
2014-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5087
2 EX-24 DOCUMENT attachment1.htm EX-24 3695
  Complete submission text file 0001209191-14-010356.txt   10227
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
MITCHELL DANIEL J (Reporting) CIK: 0001113661 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 14606309